Clinical Trial

GC012F in Patients With Autoimmune Diseases

Name: GC012F in Patients With Autoimmune Diseases — clinical trial record (NCT07072884)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label, early exploratory main clinical study to evaluate the safety and efficacy of GC012F Injection in subjects with autoimmune diseases (AID), as well as to assess its pharmacokinetic (PK) and pharmacodynamic (PD) profiles.

Trial Details

NCT Number	NCT07072884
Lead Sponsor	Qiong Fu Collaborators: Gracell Biotechnologies (Shanghai) Co., Ltd.
Conditions	Systemic Sclerosis (SSc), Idiopathic Inflammatory Myopathy (IIM)
Enrollment	15 participants
Start Date	2025-08-18
Primary Completion	2027-03-31 (estimated)
Study Completion	2029-03-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-18